LAPROPHAN, a Mediterrania Capital Partners' portfolio company, and a major player in the pharmaceutical sector in Africa and the Middle East, has announced the acquisition* of a majority stake in Botanic Pharma, a company specialising in natural food supplements.
With the integration of Botanic Pharma, Laprophan strengthens and consolidates its position in the healthcare sector. This expansion will enable the company to broaden its product portfolio in the European and African markets while increasing its capacity to export innovative and high-quality healthcare products.
The acquisition also supports Laprophan’s ambition to become a major player in the rapidly expanding global food supplements sector. Mediterrania wishes Laprophan continued success in its mission to improve the quality of life for millions of people through high-quality medicines and healthcare products.
*Subject to regulatory approvals.
cloud technology axon
Xcalibur Smart Mapping, recognised as the global leader in airborne...
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
